Correlation Between Crinetics Pharmaceuticals and SIGA Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and SIGA Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and SIGA Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and SIGA Technologies, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and SIGA Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of SIGA Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and SIGA Technologies.

Diversification Opportunities for Crinetics Pharmaceuticals and SIGA Technologies

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Crinetics and SIGA is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and SIGA Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SIGA Technologies and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with SIGA Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SIGA Technologies has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and SIGA Technologies go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and SIGA Technologies

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.65 times more return on investment than SIGA Technologies. However, Crinetics Pharmaceuticals is 1.53 times less risky than SIGA Technologies. It trades about 0.09 of its potential returns per unit of risk. SIGA Technologies is currently generating about 0.05 per unit of risk. If you would invest  5,277  in Crinetics Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  443.00  from holding Crinetics Pharmaceuticals or generate 8.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Crinetics Pharmaceuticals  vs.  SIGA Technologies

 Performance 
       Timeline  
Crinetics Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Crinetics Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Crinetics Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.
SIGA Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SIGA Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, SIGA Technologies is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Crinetics Pharmaceuticals and SIGA Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crinetics Pharmaceuticals and SIGA Technologies

The main advantage of trading using opposite Crinetics Pharmaceuticals and SIGA Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, SIGA Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SIGA Technologies will offset losses from the drop in SIGA Technologies' long position.
The idea behind Crinetics Pharmaceuticals and SIGA Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Correlations
Find global opportunities by holding instruments from different markets